PeerVoice is an independent, professional medical publishing concern focused on gathering and reporting information pertaining to clinically relevant advances and developments in the science and practice of medicine. As publishers of PeerVoice Publications, PeerVoice is solely responsible for the selection of publication topics, the preparation of editorial content and the distribution of all materials it publishes.
http://www.peervoice.com
Gesamtlänge aller Episoden: 2 days 7 hours 28 minutes
An In-Depth Look at the EMA Guidelines for Biosimilars From Creation to Care
An In-Depth Look at the EMA Guidelines for Biosimilars From Creation to Care
Biologic Treatment Decisions in RA: Considering Mechanisms, Evidence, and Patients
Go online to www.peervoice.com/h/pvr157 to view the entire programme with slides.
Immunogenicity and Anti-TNF Therapies: Understanding the Relevance for Daily Clinical Practice
Go online to www.peervoice.com/h/pvr67 to view the entire programme with slides.
Update from Paris: New Insights on JAK Inhibitors for the Treatment of Rheumatoid Arthritis
Go online to www.peervoice.com/h/pvs58 to view the entire programme with slides.
Antimicrobial Resistant Infections in the Acute Care Setting: Prevalence, Consequences, and Prevention Strategies
Go online to www.peervoice.com/h/pve50 to view the entire programme with slides.
Expert Perspectives on Immunogenicity in Psoriasis: Understanding Its Impact on Patient Outcomes
Go online to www.peervoice.com/h/pve43 to view the entire programme with slides.
Originators, Generics, and Biosimilars: How They Are Assessed
Originators, Generics, and Biosimilars: How They Are Assessed
Scoping Out Optimal Antiviral Therapy for Patients With COVID-19: Exploring the Implications of the Latest Data
Scoping Out Optimal Antiviral Therapy for Patients With COVID-19: Exploring the Implications of the Latest Data